The global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from USD 1.25 Billion in 2017, at a CAGR of 5.5 percent during the forecast period. The growth of this market is majorly driven by factors such as technological advancements in C-arms, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence.

In surgical imaging report, the market is segmented on the basis of technology, application, and region. On the basis of technology, the global market is segmented into image intensifier C-arms and Flat Panel Detector C-arms (FPD C-arms). The FPD C-arms segment is expected to register the highest CAGR during the forecast period. The high growth in this segment can be attributed to the increasing demand for minimally invasive procedures and the advantages offered by FPD C-arms such as better image quality and lower radiation exposure.

Based on application, the market is segmented into orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other applications (urologic surgeries, endobronchial and thoracic surgeries, and maxillofacial surgeries). The orthopedic and trauma surgeries segment is expected to account for the largest share and register the highest CAGR during the forecast period.

The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.

The high cost of C-arms is likely to restrain market growth. In addition to the huge purchases cost, these equipment have several other direct expenses for printers and DICOM boxes, which results in an overall increase in the total cost of ownership. Due to the requirement of significant capital expenditure, many small and medium-sized institutions find it hard to purchase C-arms. – Markets and Markets 


A New Cancer Treatment

 

Digital version